AVEFF (Avecho Biotechnology) Other Current Payables: $0.06 Mil (As of Dec. 2025)


What is Avecho Biotechnology Other Current Payables?

Avecho Biotechnology AVEFF -74.14% Other Current Payables is $0.06 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Avecho Biotechnology's Other Current Payables for the quarter that ended in Dec. 2025 was $0.06 Mil.

Avecho Biotechnology's quarterly Other Current Payables declined from Dec. 2024 ($0.10 Mil) to Jun. 2025 ($0.00 Mil) but then increased from Jun. 2025 ($0.00 Mil) to Dec. 2025 ($0.06 Mil).

Avecho Biotechnology's annual Other Current Payables increased from Dec. 2023 ($0.06 Mil) to Dec. 2024 ($0.10 Mil) but then declined from Dec. 2024 ($0.10 Mil) to Dec. 2025 ($0.06 Mil).

Avecho Biotechnology Other Current Payables Related Terms

Avecho Biotechnology Other Current Payables Historical Data

* Premium members only.

The historical data trend for Avecho Biotechnology's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avecho Biotechnology Other Current Payables Chart

Avecho Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.06 0.06 0.10 0.06

Avecho Biotechnology Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.00 0.10 0.00 0.06

Avecho Biotechnology Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.06 Mil mean?
Avecho Biotechnology (AVEFF) has a Other Current Payables of $0.06 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Avecho Biotechnology and its competitors.
Is Avecho Biotechnology's Other Current Payables too high?
Avecho Biotechnology's current Other Current Payables is $0.06 Mil.
How does Avecho Biotechnology's Other Current Payables compare to VRTX and REGN?
Avecho Biotechnology's Other Current Payables of $0.06 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Avecho Biotechnology and its competitors. Avecho Biotechnology's current Other Current Payables is $0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avecho Biotechnology stock overvalued right now?
Avecho Biotechnology (AVEFF) has a current Other Current Payables of $0.06 Mil. The current Other Current Payables is $0.06 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Avecho Biotechnology (AVEFF), the current Other Current Payables is $0.06 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avecho Biotechnology Business Description

Other Exchanges OEZ:GermanyAVE:Australia
Address Unit A8, 2A Westall Road, Clayton, Melbourne, VIC, AUS, 3168
Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches, including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.